MA02.02 Multistate Healthcare Network Underutilizes Valuable End-Of-Life Resources in Stage IV Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.323
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Image Features for the Future in Stage IV Non-Small Cell Lung Cancer

English

Applicability of a Prognostic CT-based Radiomic Signature Model Trained on Stage I-Iii Non-Small Cell Lung Cancer in Stage IV Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

P1.13-03 Ensartinib Treatment Beyond Disease Progression in Stage IV ALK+ Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

Thoroughness of Mediastinal Staging in Stage IIIA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Quality of Life in Patients With Non-Small Cell Lung Cancer

Vojnosanitetski Pregled
MedicinePharmacology
2017English

Molecular Testing for Stage IV Non–Small Cell Lung Cancer Patients With Targetable Mutations Following Disease Progression

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy